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ABSTRACT
Infrabony pocket therapy is needed to eliminate pocket wall, creating easy to clean conditions for new attachment, 
and bone regeneration. Biphasic calcium sulfate (BCS) bone grafts combined with collagen membranes are known 
to regenerate bone tissue and have good osteoconductive effects. The addition of collagen membranes promotes 
migration and proliferation of fibroblast cells, osteoblasts, and homeostasis. However, the collagen membrane is a rapid 
bioresynthesis and may cause disease transmission from animal. Acellular dermal matrix (ADMA) membrane contains 
a bioactive matrix that has the ability to support normal revascularization, cell repopulation, and tissue remodeling. 
Combination of BCS with ADMA membrane are proven to induce bone and tissue regeneration. The objective of this 
study is to determine the therapeutic effect of BSC and ADMA combination to eradicate pocket, gingival recession, 
bone recession and attachment loss. The samples were taken from 20 infrabony pocket sites divided into 2 groups. 
The first was treated by combination of BCS and ADMA, while the second group was treated by the combination 
of BCS and collagen membrane. After 1 and 3 months of flap surgery, the result was observed by probing depth 
(PD), relative attachment loss (RAL), gingival recession, alveolar bone height and radiological examination. The result 
showed the decrease of PD, RAL, gingival recession, and alveolar bone height in both two groups. However, there were 
no significant differences between those two groups. In conclusion, the combination of BCS and ADMA or BCS and 
collagen decreased the PD, RAL, gingival recession and alveolar bone height.
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INTRODUCTION
Periodontitis was an inflammatory reaction caused 
by bacteria and manifested in irreversible periodontal 
tissue destruction.1 The disease progresses 
pathologically and progressively from periodontal 
ligaments and alveolar bone with the formation of 
periodontal pockets, recessions, or both.2 Bone graft 
treatment using bone graft materials could induce 
bone formation and regenerate new attachment of 
periodontal processes.3 To determine the success 
of the periodontal pocket, there were several clinical 
parameters to determine its success, between the 
parameters of probing depth, attachment loss, and 
alveolar bone height.4
Biphasic calcium sulfate (BCS) was one of 
the bone graft materials that has its microporous 
properties, allowing stronger osteoblast infiltration 
to remain embedded and crystallize, thereby 
enabling the formation of excellent scaffolds that 
will enhance the osteoblast differentiation activity. In 
this way, the superiority of BCS makes it a potential 
material for bone graft.5,6 Reported increases in 
gingival recession due to shrinkage in bone grafts 
were mainly due to inflammatory tissue healing. 
This fact is in line with the reported findings of an 
increase in gingival recession by 1.28 mm and 1.20 
mm after 6 months of graft material installation.7,8 
The use of collagen membranes in infrared pocket 
therapy with or without the addition of bone graft 
can improve the regeneration of periodontal tissue.9 
However, the drawback of this membrane is the loss 
of space keeping ability in humid conditions, easy 
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resorption, and the risk of disease transmission to 
humans.10
Acellular dermal matrix (ADMA) could be 
used as a membrane obtained from human skin. 
This process was done by removing the dermal 
cell portion and leaving the bioactive matrix portion 
that the body needs for regeneration and healing.11 
Clinical studies using ADMA as a membrane for 
guided bone regeneration in toothless areas in the 
installation of immediate implants indicate that this 
material may serve as membranes.12 The objective 
of this study is to determine the effect therapy of 
BSC and ADMA combination to eradicate pocket, 
gingival recession, bone recession, and attachment 
loss.
MATERIALS AND METHODS
The methods of this study was approved by the 
Ethics Committee of the Faculty of Dentistry, 
Universitas Gadjah Mada (Ethical Clearance No. 
001417 / KKEP / FKG-UGM / EC / 2018). A signed 
informed consent was got from each participant 
in this study. The samples were taken from 20 
infrabony pocket sites of chronic periodontitis 
patients divided into 2 groups. The first group was 
treated by combination of BCS and ADMA, while 
the second group was treated by the combination 
of BCS and collagen membrane. 
The preparatory stage in the patient was done 
by subject selection according to inclusion and 
exclusion criteria, informed consent signing, and 
scaling and root planing of the patient. The stage of 
the study consisted of measurements of PD, RAL, 
high gingival recessions, and alveolar bone height 
using periodontal probes at the distobuccal, buccal, 
mesiobuccal, mesiolingual, lingual, and distolingual 
site on the second visit (a week after the first 
visit). The measurement of PD was performed on 
the gingival margin to the bottom of the pocket. 
The measurement of RAL was performed on the 
determined CEJ point to the bottom of the pocket. 
The height measurement of gingival recession 
was done on the gingival margin to the cemento 
enamel junction from the vertical direction, and the 
measurement of the height of the alveolar bone was 
performed on the CEJ and the most apical base of 
the defect from the vertical direction of the X-ray of 
CBCT.
The surgery was performed on the patient 
by firstly taking asepsis in the surgical area. 
Infiltration of anesthesia was carried out on the 
area of  operation and continued with full vertical 
and sulcular incidents of full-thickness flap. The 
flap was observed and debridement was conducted 
on the defect area with scaling root planning and 
curettage. Tetracyclin HCL of 75 mg / ml was 
applied on the root surface with sterile pellet 
cotton for 3 minutes, which was replaced every 30 
seconds, and rinsed with aquadest. Furthermore, 
BCS material was applied to bone defects and it 
was closed with ADMA membrane in group I and 
collagen membrane in group II, which have been 
prepared before. The flap was positioned towards 
the coronal until it closed the collagen membrane. 
Afterwards, it was stitched and covered with a 
periodontal dressing.
The post-surgery patient was informed and 
instructed about how to care for postoperative tooth 
and mouth. He was required to have a control 7 days 
later to release periodontal dressing. On the 30th day 
and 90th day, PD, CALs, high gingival recessions, 
and alveolar bone height were measured.
RESULTS
In this study, the data were collected from 
clinical parameters and radiological examination 
measurements in two groups of chronic periodontitis 
patients with infrabony defect. Regenerative 
treatment was done using open flap method with 
addition of BCS. Membrane of ADMA was applied 
in group I, while treatment using open flap method 
was done with the addition of BCS, and collagen 
membrane was done in group II. Data obtained in 
this research were PD, RAL, high gingival recession, 
alveolar bone damage, and radiological examination.
Table 1 and Figure 1 show the highest mean of 
PD in the BCS + ADMA membrane group on day 0 
(baseline), 7.30 ± 1.64 mm. The lowest mean of PD 
was in BCS + collagen membrane on day 90. The 
initial value of PD measurement differed between 
the two treatment groups, so it was necessary to 
see the magnitude of the reduction difference of PD 
 




in each group for further significance test. The data 
in Table 2 indicates that the average reduction of 
PD was highest in the BCS + collagen from day 0 to 
day 90, and the lowest reduction value in the BCS + 
collagen membrane group was on day 30 to day 90. 
The mean value of PD reduction was greater in the 
BCS + membrane group of ADMA in all groups and 
it was greater than the mean reduction value in the 
BCS + collagen membrane group. Mann-Whitney 
U test of PD reduction in all groups showed a 
significance value of p>0.05, and thus indicating no 
significant difference between groups at the same 
time (Table 3). 
Tables 4 and 5 demonstrate a significant 
difference of PD reduction at each observation time 
for the same group, except on the day 0 to day 30 
and day 0 to day 90 on BCS + collagen membrane 
group. Table 6 and Figure 2 depict the highest 
average RAL in the BCS + ADMA membrane group 
on day 0 (baseline). The average RAL was at the 
lowest in the BCS + collagen membrane group on 
day 90. It was important to note the difference of 
RAL reduction in each group because the initial 
value of RAL measurement was different for further 
significance test.
The data in Table 7 shows that the average 
RAL reduction was at the highest in the BCS + 
collagen membrane group on day 0 to day 90, and 
the reduction value of PD was at the lowest in the 
BCS + collagen membrane group on day 30 day to 
90. The mean value of RAL reduction was greater 
in the BCS + collagen membrane group than in the 
BCS + membrane ADMA group. Except on day 30 
to 90, the mean RAL value of the BCS + group of 
ADMA membrane was comparable to that in the 
BCS + collagen membrane group.
Table 8 illustrates the results of the Mann 
Whitney U test reduction RAL test with a significance 
value of p>0.05, so that there was no statistically 
significant difference between groups on day 0 to 
day 30, day 30 to day 90, and day 0 to day 90. 
Tables 9 and 10 delineate a significant difference 
of RAL reduction at each observation time for the 
same group.
Table 11 and Figure 3 highlight the highest 
mean gingival recession in the BCS + ADMA 
membrane group on day 30. The highest rate of 
gingival recession was at the lowest in the BCS + 
collagen membrane group on day 90.
The data in Table 12 indicates that the mean 
reduction of gingival recession height was at the 
highest on day 30 of BCS + ADMA membrane 
group to day 90, and the reduction value of gingival 
recession height was at the lowest in the BCS + 
ADMA membrane group on day 0 to day 30. The 
mean rate of gingival recession height reduction 
was greater in the BCS + collagen membrane group 
in all groups except on day 30 to 90 compared 
to the mean reduction value in the BCS + ADMA 
membrane group.
Mann-Whitney U test results for the reduction 
of gingival recession height in all groups showed a 
significance value of >0.05, which means that there 
was no statistically significant difference between 
groups in the measurement of day 0 to day 30, day 
30  to day 90, and day 0 to day 90 (Table 13). Table 14 
and 15 present no significant difference in the high 
reduction of gingival recession at each observation 
time in all groups of both BCS + membrane groups 
ADMA and BCS + collagen membranes.
Table 16 shows the highest mean alveolar 
bone in the BCS + ADMA membrane group on day 
0 (baseline). The average height of the alveolar 
bone was at the smallest in the BCS + collagen 
membrane group on day 90. The significance level 
of the paired t-test parametric obtained p value 
<0.05, which means that there were significant 
differences in alveolar bone height improvement 
between observation times in each group (Table 
17).
Initial values  of alveolar bone height 
measurement differed between the two treatment 
groups, so it was necessary to see the magnitude of 
the high-alveolar bone reduction difference in each 
group for subsequent significance tests. The data 
in the Table 18 shows that the high alveolar bone 
reduction rate in the BCS + collagen membrane 
group was higher than the BCS + ADMA membrane 
group. The result of the independent t-test on the 
high alveolar bone reduction showed a significance 
value of p>0.05, meaning that there was no 
statistically significant difference between the 
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BCS + ADMA membrane group and the BCS + 
collagen membrane group (Table 19).
Table 1. The mean and standard proportion of probing depth 






Baseline 10 7.30 ± 1.64 6.30 ± 0.67
Day 30 10 2.90 ± 0.99 2.30 ± 0.67
Day 90 10 2.10 ± 0.74 1.80 ± 0.63
Figure 1. Average diagram of probing depth (mm)
Table 2. Mean and standard probing depth reduction (PD) by 
observation time and treatment group (mm)
Time n




Day 0 to day 30 10 4.40 ± 1.65 4.00 ± 0.82
Day 30 to day 90 10 0.80 ± 1.03 0.50 ± 0.71
Day 0 to day 90 10 5.20 ± 1.32 4.50 ± 0.85
Table 3. Mann-Whitney U test of probing depth (PD) reduction 
between the treatment group
Time Signification Notes
Day 0 to day 30 0.529 Not significant
Day 30 to day 90 0.796 Not significant
Day 0 to day 90 0.218 Not significantt
Table 4. Wilcoxon test result on pocket depth reduction (PD) by 
observation time in group BCS + ADMA membrane (mm)
PD reduction BCS + ADMA membrane
0-30 30-90 0-90




Table 5. Wilcoxon test result on pocket depth (PD) reduction 
by observation time in BCS + Collagen membrane Group (mm)
Pocket depth (PD reduction)
BCS + Collagen membrane
0-30 30-90 0-90




Table 6. Mean relative attachment loss (RAL) and standard 
deviation by observation time and treatment group (mm)
Time n
BCS + ADMA 
membrane
BCS + collagen 
membrane
Day 0 10 13.20 ± 1.69 12.30 ± 1.64
Day 30 10 9.30 ± 1.83 7.40 ± 1.78






























































BCS + Collagen membrane
Figure 2. Average diagram of relative attachment loss (mm)
Table 7. Mean and standard raw reduction of relative attachment 
loss (RAL) according to observation time and treatment group 
(mm)
Time n
BCS + ADMA 
membrane 
 BCS + collagen 
membrane
Day 0 to day 30 10 3.90 ± 0.99 4.90 ± 1.450
Day 30 to day 90 10 1.3 ± 0.95 0.90 ± 0.990
Day 0 to day 90 10 5.20 ± 1.48 5.80 ± 1.140
Table 8. Result of Mann-Whitney U test against reduction 
relative attachment level (RAL) among treatment groups
Time Level of significance         Notes
Day 0 to day 30 0.105 Not Significant
Day 30 to day 90 0.436 Not Significant
Day 0 to day 90 0.353 Not Significant
Table 9. Wilcoxon test results on relative attachment level (RAL) 
reduction by observation time in BCS + ADMA membrane group 
RAL reduction
BCS + ADMA membrane
0-30 30-90 0-90





Table 10. Wilcoxon test result on relative attachment level (RAL) 
reduction by observation time in BCS + collagen membrane 
group
RAL reduction BCS + collagen membrane0-30 30-90 0-90








Table 11. Average and standard deviation of gingival recession 
height by observation time and treatment group (mm)
Time n
BCS + ADMA 
membrane  
BCS + Collagen 
membrane
Day 0 10 3.30 ± 2.54 2.10 ± 0.74
Day 30 10 3.50 ± 2.46 1.90 ± 0.57
Day 90 10 3.00 ± 2.36 1.60 ± 0.52
Figure 3. Average diagram of gingival recession height (mm)
Table 12. The mean and standard deviation of gingival recession 
height reduction by observation time and treatment group (mm)
Time n
BCS + ADMA 
membrane 
BCS + collagen 
membrane 
Day 0 to day 30 10 -0.20 ± 1.03 0.20 ± 0.79
Day 30 to day 90 10 0.50 ± 0.97 0.30 ± 0.67
Day 0 to day 90 10 0.30 ± 1.06 0.50 ± 0.71
Table 13. Mann-Whitney U test results against gingival recession 





Day 0 to day 30 0.353 Not significant
Day 30 to day 90 0.796 Not significant
Day 0 to day 90 0.481 Not significant
Table 14. Wilcoxon test result on gingival recession height 
reduction by observation time in BCS + ADMA membrane group
Reduction of gingival recession 
height
BCS + ADMA 
membrane
0-30 30-90 0-90




Table 15. Wilcoxon test result on reduction of gingival recession 
height by observation time in BCS + collagen membrane group
Reduction of gingival 
recession height
BCS + collagen membrane
0-30 30-90 0-90




Table 16. Average and standard deviation of alveolar bone 
height by observation time and treatment group (mm)
Time n
BCS + ADMA 
membrane
BCS + collagen 
membrane
Day 0 10 9.76 ± 4.54 8.17 ± 2.60
Day 90 10 8.81 ± 4.39 6.94 ± 2.68
Table 17. Parametric paired t-test results on alveolar bone 





BCS + ADMA membrane 0.000 Significant
BCS + collagen membrane 0.002 Significant
Table 18. Average and standard deviation of alveolar bone 
height reduction by observation time and treatment group (mm)
Time n
BCS + ADMA 
membrane 
BCS + collagen 
membrane
Day 0 to day 90 10 0.95 ± 0.50 1.23 ± 0.87
Table 19. T-test results of alveolar bone height reduction among 
treatment groups
Observation time Level of significant Notes
Day 0 to day 90 0.396 Not significant
DISCUSSION
Statistical test results on probing depth decrease, 
relative attachment loss, and high gingival recession 
between BCS + ADMA membrane group and 
BCS + collagen membrane group showed 
insignificant results. The ADMA membrane has a 
bioactive matrix consisting of collagen, elastin, and 
blood vessel channels. In addition, bioactive proteins 
have the ability to support natural revascularization, 
cell repopulation and tissue remodeling leading 
to good tissue regeneration. The existence of 
this matrix structure can decrease the induced 
response of excessive inflammation.13 On the other 
hand, the ADMA membrane has a tendency to have 
an extended healing process due to delayed blood 
vessel formation of the ADMA membrane. ADMA 
membranes can not perform anastomose with the 
underlying tissue, so it takes time for angiogenesis 
to occur.14 
Collagen membranes can induce more 
proliferation of fibroblasts and osteoblasts. In 
addition, the collagen membrane has semipermiabel 

































BCS + ADMA Membrane
BCS + Collagen Membrane
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presence of cell attachment on the membrane 
surface stimulates tissue regeneration.15 There were 
deficiencies in collagen membrane, such as faster 
absorption. Such deficiency caused poor wound 
healing process because the collagen membrane 
had been absorbed by the body on the 14th day, 
while the phase of peak proliferation occurred at 
week 2 to week 3.16 The healing process of surgery 
began immediately after suturing, and lasted over 
time from the phases of hemostasis, inflammation, 
proliferation, and remodeling.3 In the hemostasis 
phase, the space between the flap and the surface 
of the bone was filled by a blood clot consisting of 
fibrins with large polymorphonuclear leukocytes, 
erythrocytes and debris from damaged cells with 
capillaries at the wound end. After the hemostasis 
phase, the healing process continued with an 
inflammatory phase that peaked from day 2 to day 
3. Then, it proceeded with a proliferation phase that 
peaked at week 2 to week 3, while the remodeling 
phase began at the peak of the proliferation phase 
at week 3 or day 21, where optimal results of 
intrabony damage repair can be seen from the 
reduction of probing depth.16
The data of a high alveolar bone value of 
day 30 is lower than day 0. Higher alveolar bone 
values  indicate bone repair where a decrease in 
alveolar bone height indicates a periodontal tissue 
regeneration that appears to be a radiopaque area 
in the x-ray image.17 This is consistent with studies 
using biphasic calcium sulfate as a socket therapy 
after retraction with visible results of vital bone 
formation.18
Healing of bone fracture occurred after one 
month of bone grafting and after 3 months as 
evident on radiographic examination. The process 
of mineralization and bone density will increase 
significantly six months after bone graft planting.19
The mean reduction of alveolar bone damage 
between day 0 to day 90 of BCS + collagen 
membrane group was greater than that of 
BCS + ADMA membrane group. The reduction 
results in the BCS + group of larger collagen 
membranes may be attributed to the collagen 
membrane which had the potential to induce 
osteoblasts, thereby resulting in bone regeneration.9
High alveolar bone reduction test resulting 
in differences in alveolar bone damage between 
BCS + collagen membrane group and BCS + ADMA 
membrane group was not significant. This showed 
the same alveolar bone regeneration between the 
two groups. Both groups were equally using BCS as 
bone graft. The presence of BCS will provide scafold 
in bone formation. In addition, BCS can increase 
osteoblast differentiation activity to improve bone 
regeneration.5 The maturation of bone graft in the 
laminar bone requires varying healing time, ranging 
from 3 to 6 months depending on some factors, 
such as age, wound healing factor, and bone 
damage measurement in bone grafted areas.20
CONCLUSION
Research on the difference of therapeutic results 
between the addition of acellular dermal matrix 
membrane and collagen membrane on biphasic 
calcium sulfate bone graft showed no differences in 
the increase of probing depth, relative attachment 
loss, high gingival recession, and alveolar bone 
height in either acellular dermal matrix collagen 
membrane.
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